Status:

RECRUITING

EPC Performance Investigation for StereoElectroEncephaloGraphy

Lead Sponsor:

Alcis

Conditions:

Epilepsy

Eligibility:

All Genders

18-65 years

Brief Summary

The objective of this multicentre study is to collect preoperative, intra operative, early, short, intermediate and mid-term(one years) on the related clinical complications and functional outcomes of...

Detailed Description

Outcome data collected from this study will provide the basis for Post-Market Surveillance (PMS) reporting, Clinical Study Report (CSR), Clinical Evaluation Report (CER) on Alcis devices and support p...

Eligibility Criteria

Inclusion

  • To be included, patients must be:
  • 18 months to 65 years
  • Patient with drug-resistant and disabling focal epilepsy
  • Informed and willing to sign an informed consent form approved by EC / For minors: if one of the parents cannot consent within the timeframe provided by the protocol, then only one parent's signature is required
  • Affiliation to the social security or foreign regime recognized in France
  • For prospective inclusion: Patient considered for SEEG exploration as part of pre-surgical assessment of epilepsy
  • For ambispective inclusion:
  • Must have undergone an SEEG exploration with one ALCIS device before the date of the initiation visit
  • Follow-up visits (at least 12-month) must be prospective
  • Must have complete information available for each completed visit (demographics, preoperative information, implantation information, device details) \*.

Exclusion

  • • Not able to comply with the study procedures based on the judgment of the assessor (e.g. cannot comprehend study questions, inability to keep scheduled assessment times)
  • Any medical condition that could impact the study at investigator's discretion (e.g. allergy…)
  • Pregnant women (contraindication to SEEG exploration)
  • Adult subject to legal protection measure
  • Skull thickness inferior at 2 mm

Key Trial Info

Start Date :

April 29 2022

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

December 30 2024

Estimated Enrollment :

74 Patients enrolled

Trial Details

Trial ID

NCT05223985

Start Date

April 29 2022

End Date

December 30 2024

Last Update

August 5 2024

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Centre d'Investigation Clinique : Equipe Timone Adultes CPCET

Marseille, France, 13354

2

Pôle Investigation - Fondation Adolphe de Rothschild

Paris, Île-de-France Region, France, 75019